Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 385

1.

Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D.

Ann Epidemiol. 2006 Jan;16(1):63-70. Epub 2005 Jul 21.

PMID:
16039877
2.

Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada.

Curkendall SM, Mo J, Glasser DB, Rose Stang M, Jones JK.

J Clin Psychiatry. 2004 May;65(5):715-20.

PMID:
15163261
3.

Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.

Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.

Ann Intern Med. 2008 Sep 16;149(6):380-90.

PMID:
18794557
4.

Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.

Brooks TW, Creekmore FM, Young DC, Asche CV, Oberg B, Samuelson WM.

Pharmacotherapy. 2007 May;27(5):684-90.

PMID:
17461703
7.

[Comorbidity in chronic obstructive pulmonary disease].

Karoli NA, Orlova EE, Markova AV, Rebrov AP.

Ter Arkh. 2008;80(3):20-3. Russian.

PMID:
18441678
8.
9.

Cardiovascular morbidity associated with nonadherence to statin therapy.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW.

Pharmacotherapy. 2005 Aug;25(8):1035-43.

PMID:
16207093
10.

Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.

Sin DD, Man SF.

Can J Physiol Pharmacol. 2005 Jan;83(1):8-13. Review.

PMID:
15759045
11.

Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.

Leavitt BJ, Ross CS, Spence B, Surgenor SD, Olmstead EM, Clough RA, Charlesworth DC, Kramer RS, O'Connor GT; Northern New England Cardiovascular Disease Study Group.

Circulation. 2006 Jul 4;114(1 Suppl):I430-4.

12.

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.

Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM.

J Am Coll Cardiol. 2006 Jun 20;47(12):2554-60. Epub 2006 May 2.

13.

Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.

Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falcó M, Muñoz J.

Am J Emerg Med. 2007 Jun;25(5):515-22.

PMID:
17543654
14.

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB.

Thorax. 2008 Apr;63(4):301-5. Epub 2007 Oct 19.

PMID:
17951276
15.

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Johannessen A, Omenaas ER, Bakke PS, Gulsvik A.

Thorax. 2005 Oct;60(10):842-7. Epub 2005 Aug 5.

16.

Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.

Rowe BH, Villa-Roel C, Guttman A, Ross S, Mackey D, Sivilotti ML, Worster A, Stiell IG, Willis V, Borgundvaag B.

Acad Emerg Med. 2009 Apr;16(4):316-24. doi: 10.1111/j.1553-2712.2009.00366.x. Epub 2009 Mar 6.

17.

[Chronic obstructive pulmonary disease and cardiovascular system].

Gürgün A, Gürgün C.

Tuberk Toraks. 2008;56(4):464-71. Review. Turkish.

PMID:
19123087
18.

Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Curkendall SM, Lanes S, de Luise C, Stang MR, Jones JK, She D, Goehring E Jr.

Eur J Epidemiol. 2006;21(11):803-13. Epub 2006 Nov 15.

PMID:
17106760
19.

Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population.

Johannessen A, Omenaas E, Bakke P, Gulsvik A.

Int J Tuberc Lung Dis. 2005 Aug;9(8):926-32.

PMID:
16104642
20.

Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications.

Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD.

Curr Med Res Opin. 2008 Apr;24(4):1123-30. doi: 10.1185/030079908X280699 . Epub 2008 Mar 7.

PMID:
18331668

Supplemental Content

Support Center